WYAMYCIN S Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Wyamycin S, and when can generic versions of Wyamycin S launch?
Wyamycin S is a drug marketed by Wyeth Ayerst and is included in one NDA.
The generic ingredient in WYAMYCIN S is erythromycin stearate. There are one hundred and three drug master file entries for this compound. Additional details are available on the erythromycin stearate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for WYAMYCIN S?
- What are the global sales for WYAMYCIN S?
- What is Average Wholesale Price for WYAMYCIN S?
Summary for WYAMYCIN S
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 26 |
| Patent Applications: | 1 |
| DailyMed Link: | WYAMYCIN S at DailyMed |
US Patents and Regulatory Information for WYAMYCIN S
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Ayerst | WYAMYCIN S | erythromycin stearate | TABLET;ORAL | 061675-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Ayerst | WYAMYCIN S | erythromycin stearate | TABLET;ORAL | 061675-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
